Gerard Sweeney
Analyst · Manny Korchman with Citigroup. Your line is now open
Sarah, Thank you very much. Good morning, everyone, and thank you for participating in our first quarter 2021 earnings call. As per our normal process on today's call with me are George Johnstone, our Executive Vice President of Operations; Dan Palazzo, our Vice President and Chief Accounting Officer; Tom Wirth, our Executive Vice President and Chief Financial Officer. Prior to beginning certain information discussed during our call may constitute forward-looking statements within the meaning of the federal securities law. Although we believe estimates reflected in these statements are based on reasonable assumptions, we cannot give assurance that the anticipated results will be achieved. For further information on factors that could impact our anticipated results please reference our press release as well as our most recent annual and quarterly reports that we filed with the SEC. First and foremost, we hope that everyone is – continue to be safe, healthy, engaged and looking forward to return to some semblance of normalcy. The pandemic continues to disrupt but with the vaccine deployment being accelerated we are on a path towards that normalcy. There is more optimism about the economy opening up and we're hearing that directly from many of our 1,200 tenants. Our portfolio remains about 15% to 20% occupied, and the predominance of tenants that returned thus far are the small and medium size employers. What's interesting though is many restrictions imposed by governmental agencies are being gradually loosened by state local governments, but that happened just recently here in Pennsylvania and Philadelphia, and we believe that those changes will definitely accelerate the return to the workplace. So during our prepared comments today we’ll review our first quarter results, discuss progress on our 2021 business plan, and update you on our recent transaction development activity. Tom will after that provide a detailed financial review, and subsequent to that Dan, George, Tom and I are available for any questions. First, I guess a general update on COVID-19’s impact. Consistent with all applicable guidelines our buildings have remained in a doors open, lights on condition. Each of our buildings has a customized return to workplace presentation that’s been distributed to our tenants, and our property teams are in active discussions with many tenants on coordinating a safe return. These discussions have enabled us to understand the tenants’ concerns and aid them in their transition plans. We have heard from about a third of our tenants directly in the last several weeks and the trend lines from those are indicating three basic milestone dates, July 1st, Labor Day and in the fourth quarter of 2021. We’ve heard from again from about almost 400 tenants and clearly the small and the mid-sized tenants looked to be returning to the workplace first before the larger tenants. As we look at our business plan certainly from a revenue standpoint our key priority has been to focus on tenants whose spaces role in the next two years. And those efforts have been very successful and they've significantly reduced our Ford rollover exposure to an average of only 6% for the period of 2021 through 2023 or 8% annual rollover for the years 2023 to 2024. We do remain focused on revenue and our earnings growth and key near-term earnings drivers for us are leasing up our key vacancies that we anticipate will be absorbed in the next 24 months. And we do anticipate that those leases will generate around 10% cash and GAAP mark to market and could generate between $0.07 to $0.10 per share in additional earnings. We do have 405 Colorado and 3000 market stabilize in next year and the continued performance of our early renewal program and to add to our early the early rollover stats when we look at our company from 2021 through 2026 we are through the efforts of our leasing teams on the early renewals were below 10% annual rollover in each year through 2026. So looking at first quarter results we did post FFO in line with consensus. We've made very good progress on many of our 2021 business plan objectives. We achieved a 90% target on our expected revenue range midpoint and as anticipated our business plan we did have 165,000 square feet of negative absorption during the quarter. However we've already leased 72% of that at an average cash to mark to market of over 19%. Rent collections continued to be among the best in our sector and we have collected over 99% of first quarter billings. First quarter capital costs also remain well below our historical averages and we’ve been in our 2021 business plan range as we continue to have good success in generating short-term extensions that require minimal capital outlay. And certainly George is available to answer any detailed questions on that front. Tenant retention came in at 52% and our portfolio lease percentage remain within our business plan range. First quarter cash mark-to-market was positive 5% and our GAAP mark-to-market was a positive 8.3%, both of those results are below our full year ranges. However, based on leases already executed with higher mark-to-markets we will be within our business plan ranges for 2021. We also expect all of our regions will post positive mark-to-market results on both a cash and a GAAP basis. Looking at same-store, our first quarter GAAP same-store was 0.9% negative below our 0.2% range and our cash same-store was 1.4% negative below our range of 3% to 5% similar to the mark-to-market tenants taking occupancy later this year will enable us to achieve our 2021 business plan targets. It's also important to note that with the exception of the net DC all of our regions and operations are expected to post positive same-store results. Net DC will remain negative while 1676 International continues through its lease-up phase. But during the quarter we did actually the 75,000 square foot lease with a large professional service firm for a 10-year term with 2.5% bumps and that represents about 30% of our current vacancy. In addition to that, maybe more importantly our overall leasing act – leasing In addition to that and maybe more importantly, our overall leasing and tour activity is accelerating and our pipeline remains about 600,000 square feet. Tom will give us more detail on the balance sheet, but we are still forecasting a debt to EBITDA multiple in the range of 6.3 times to 6.5 times depending upon the timing of some future developments search for the balance of the year. We have to keep in mind that we are in the beginning phases of a transition in the return to work journey. And we know everyone's looking for data points. We believe it will take three quarters or so to fully play out, and we know everyone is looking for recovery data points. And we have several encouraging signs we'd like to share. Recently published reports indicate that 80% of tenants want to tour spaces virtually before committing to an in-person tour at least at this point in the cycle. We experienced the same trend within our portfolio. So during the quarter, we had a total of 1,500 virtual tours inspecting over a 725,000 square feet of space. We think that was a contributing factor that led to a 40% increase in physical tours over the fourth quarter of last year. Our overall pipeline stands at 1.2 million square feet with approximately 165,000 advanced stages of lease negotiations and the overall pipeline did increase by over 400,000 square feet during the quarter. We are clearly seeing from the pipeline additions that the return to work movement will accelerate and the flight to quality higher quality office buildings is becoming increasingly clear. Some of liquidity analysis and dividend coverage standpoint, we have excellent liquidity. And as Tom will touch on anticipate having just shy of $470 million as Tom will touch on anticipate having just shy of $470 million line of credit availability by the end of the year. We have no unsecured bond matures until 2023 and a fully encumbered our wholly-owned asset base. Our dividend is extraordinarily well covered with a 56% FFO and a 70% cash payout ratio, our five-year dividend growth rate has been 5.3% versus a peer average of 3.6% and we have grown our CAD during that same five-year period at a 7.8% annual rate versus a peer average of less than 4%. And quickly looking at some investment activity, during the first quarter we made two announcements. We are very excited to have been selected by the University of Maryland as an exclusive developer for five-acre mixed-use development located within the university's Discovery District. This project will consist of innovation research, life science and multifamily residential units. Prior to commencing any development we need to obtain local zoning approvals and complete the design development process. We also would target 50% pre-lease before we start the first phase. Design development is underway now, we hope to receive approvals by the second half of 2022. And the first phase, again subject to the pre-leasing standard and market conditions, consists of about 250,000 square feet of space. In addition, we had another announcement that in order to meet the growing need for immediate last space delivery in University City, Philadelphia, we have partnered with the Pennsylvania Biotechnology Center to create a 50,000 square foot life science incubator that will be located at Cira Centre. The project is named B.Labs and will open in the fourth quarter of 2021. Since the announcement just a few weeks ago we've already built a pipeline for about 35% of that space from a production assets standpoint all of our Garza Four point 650 Park, 155 King of Prussia all approved priced ready to go subject at least to pre-leasing. And we continue to see increasing demand for those types of products. You're looking at our existing development pipeline for Schuylkill Yards West that project commence construction on March the 1st. The project will be built with 7% blended yield. It will consist of 326 apartment units 100,000 square feet of life science space 100,000 square feet of high bay innovative office and street retail. We have a very active pipeline for this project or for both the life science and the office components. As we noted in the supplemental package and the press release we are proceeding down the path on a construction loan financing package and expect to close that in the next 90 days at a 65% loan to cost. And given the front loading of the equity commitment of the $100 million we don't really expect the first construction loan draw to occur until the tail end of the first quarter of 2022. On 405 Colorado that project - it has achieved substantial completion. We currently have a pipeline of just shy of 300,000 square feet of space. Activity is definitely picking up. We've had four new tours in the last week alone and are under an LOI for full four users that we hope to convert to a full four lease in the next 30 days. 3000 Market it was our 64,000 square foot life science renovation Schuylkill Yards that project will finish construction later this year. The building as is disclosed is fully leased for 12 years with the lease commencing in Q4 2021 at a development yield of 9.6%. Just some further amplifications on Schuylkill Yards and an update on Broadmoor. Within Schuylkill Yards, the strong life science push continues. As we've noted the overall master plan can accommodate that 3 million square feet of life science space or plans for 3151 market or 500,000 square foot life science building is well underway pricing is done. Design development is complete. Active marketing is underway. And we have a very healthy pipeline and are in discussions with several key tenants. Our goal does remain being able to start that project assuming market conditions permit later this year. And then another note on Schuylkill Yards, as we previously mentioned we’re converting floors two through nine in our series Center Building to Life Science. That's a total of about 188,000 square feet. The incubator will take about 50,000 square feet of that. We've already leased about 47,000 square feet of that other life science tenants. So that 91,000 square feet of near-term life science space delivery that we can also achieve within Series center. On Broadmoor, we are advancing Block A in the first stage of Block F that aggregates 350,000 square feet of office and 613 apartment units at a total cost about $360 million. As we mentioned on the previous call we are looking for a partner on that project. We have received excellent responses from very high quality institutions and we'll make a selection in the next week or so and then proceed through documentation and debt financing shortly thereafter. Our plan remains to start the residential component of Block A which is 341 units at a cost of about $119 million by Q3 2021. And the office start of 351,000 square feet is targeted to commence upon achieving a pre-lease and we have decent activity that we’re focused on there. So with that, Tom will now provide an overview of our financial results.